Sep 5 |
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Sep 4 |
Adverum Biotechnologies to Participate in Upcoming Fall Investor Conferences
|
Sep 3 |
Wall Street Analysts See a 332.28% Upside in Adverum Biotechnologies (ADVM): Can the Stock Really Move This High?
|
Aug 12 |
Adverum Biotechnologies GAAP EPS of -$0.89 beats by $0.58
|
Aug 12 |
Adverum Biotechnologies: Q2 Earnings Snapshot
|
Aug 12 |
Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights
|
Aug 2 |
Adverum Biotechnologies to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
|
Aug 1 |
Around $88M Bet On NextDecade? Check Out These 3 Stocks Insiders Are Buying
|
Aug 1 |
Adverum Biotechnologies Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for Ixo-vec for the Treatment of Wet AMD
|
Jul 19 |
More Than $10M Bet On Appian? Check Out These 3 Stocks Insiders Are Buying
|